Tag: Migraine Disorders
Similar treatment needs for high-frequency episodic and low-frequency chronic migraine
Remote electrical neuromodulation useful for adolescents with migraine
Concomitant preventive medication has no impact on efficacy of ubrogepant
No new cardiovascular safety concerns with long-term use of lasmiditan
Less medication use and fewer doctor visits with galcanezumab in treatment-resistant migraine
Real-world evidence reveals physicians’ perception of erenumab
Early initiation of lasmiditan improves migraine outcomes
Fremanezumab effective in patients with migraine and comorbid depression
Long-term onabotulinumtoxinA improves quality of life in migraine
Sustained shift in migraine status using galcanezumab
Worldwide survey shows substantial burden of migraine
Long-term efficacy and safety of fremanezumab in treatment-resistant migraine
Injection-site reactions with galcanezumab are mild and self-limiting
Migraine as a cyclical functional disorder
Reassuring real-world safety profile of 3 CGRP inhibitors
Long-term cardiovascular safety of erenumab
Real-world data for erenumab in Germany
Eptinezumab in chronic migraine and medication-overuse headache
Fremanezumab tolerability in cardiovascular patients with migraine
